Searchable abstracts of presentations at key conferences in endocrinology

ea0035p196 | Cardiovascular Endocrinology & Lipid Metabolism | ECE2014

Fetuin-A as a marker of cardiovascular risk in patients with type 2 diabetes

Dabrowska Anna , Tarach Jerzy , Wojtysiak-Duma Beata , Malecha-Jedraszek Arleta , Torun-Jurkowska Anna , Kudlicki Janusz , Donica Helena

Introduction: It is known that type 2 diabetes increases the risk of cardiovascular disease. Fetuin-A is a multifunctional serum glycoprotein and its role in the pathogenesis of type 2 diabetes, atherosclerosis and cardiovascular disease is still discussed.Material and methods: The study was conducted in 36 patients (12 F and 24 M) with type 2 diabetes mellitus (DM2) and acute coronary syndrome (ACS), aged mean 70.22±7.62. The group was divided into...

ea0035p197 | Cardiovascular Endocrinology & Lipid Metabolism | ECE2014

Osteoprotegerin as a marker of myocardial damage in patients with type 2 diabetes and acute coronary syndrome

Dabrowska Anna , Tarach Jerzy , Malecha-Jedraszek Arleta , Wojtysiak-Duma Beata , Torun-Jurkowska Anna , Kudlicki Janusz , Donica Helena

Introduction: It’s known that type 2 diabetes increases the risk of cardiovascular disease. Silent myocardial ischemia occurs frequently in diabetics and may result in more severe coronary artery disease. Osteoprotegerin (OPG) is a glycoprotein secreted mainly by osteoblasts but it’s also produced by heart muscle. Its role in the pathogenesis of type 2 diabetes, atherosclerosis and future cardiovascular events is still discussed.Material and me...